Webinar Replay: Private Markets in 2026
Controversial business involvement screening is moving beyond its origins as a compliance exercise. Under frameworks...
Following the success of SESAMm’s AI-Powered Deal Screening Reports, we’re expanding our due diligence suite with a new...
Screening a portfolio for controversial business involvement is fundamentally different in public markets than in...
There’s no denying that ESG risk exposure in the pharmaceutical industry is high. This stems from the intense...
SESAMm is pleased to announce that Nathalie Wallace is joining our Advisory Board. Nathalie brings more than 20 years...
As 2026 kicks off, I want to take a moment to reflect on the year we’ve just closed. 2025 was an important year for...
The Sustainable Finance Disclosure Regulation (SFDR) is the EU’s framework for governing how sustainability...
The biotech industry faces significant ESG risks, particularly in governance. Social and operational risks are less...
Human rights concerns took center stage in November, with rising scrutiny on how digital platforms and luxury brands...
When Meta's market value declined by $307 billion over four trading days in October 2025, it demonstrated a fundamental...